[Neuropharmacological findings after chronic administration of haloperidol, loxapine and clozapine].
D000818:Animals; D002375:Catalepsy / Q000188:drug therapy; D002420:Cauda Equina / Q000187:drug effects; D003984:Dibenzazepines / Q000494:pharmacology*; D003989:Dibenzoxazepines / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004361:Drug Tolerance; D004569:Electroencephalography; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D012890:Sleep / Q000187:drug effects; D012894:Sleep Stages; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*
D003984:Dibenzazepines; D003989:Dibenzoxazepines; D010879:Piperazines; D014149:Tranquilizing Agents; D006220:Haloperidol
Neuropharmakologische Befunde unter chronischer Verabreichung von Haloperidol, Loxapin und Clozapin